APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetic Research Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacokinetic Research Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026190 pages

Choose your research edition.

Industry ResearchPharmacokinetic Research Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetic Research Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacokinetic Research Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetic Research Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetic Research Service Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Pharmacokinetic Research Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacokinetic Research Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetic Research Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetic Research Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacokinetic Research Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacokinetic Research Service include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences and Allucent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacokinetic Research Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetic Research Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetic Research Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacokinetic Research Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacokinetic Research Service Segment by Company

Eurofins

PPD

LabCorp

Charles River

BioPharma Services

Biotrial

QPS Holdings

Altasciences

Allucent

Admescope

CTI

WuXi AppTec

GenScript

Wuxi Biologics

Medicilon

Pharmaron

Frontage

Shanghai Model

Pharmacokinetic Research Service Segment by Type

In Vitro and Radioactive ADME

In Vivo PK and PD

New Drugs and New Molecules

Other

Pharmacokinetic Research Service Segment by Application

Pharmaceutical Industry

Government and Ministry of Health

Agriculture and Chemical Industry

University

Pharmacokinetic Research Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Research Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Research Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Research Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacokinetic Research Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetic Research Service industry.

Chapter 3: Detailed analysis of Pharmacokinetic Research Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetic Research Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetic Research Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of In Vitro and Radioactive ADME Table 3. Key Players of In Vivo PK and PD Table 4. Key Players of New Drugs and New Molecules Table 3. Key Players of Other Table 4. Global Pharmacokinetic Research Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Industry Table 6. Key Players of Government and Ministry of Health Table 7. Key Players of Agriculture and Chemical Industry Table 8. Key Players of University Table 9. Global Pharmacokinetic Research Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pharmacokinetic Research Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pharmacokinetic Research Service Market Share by Region (2021-2026) Table 12. Global Pharmacokinetic Research Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pharmacokinetic Research Service Market Share by Region (2027-2032) Table 14. Pharmacokinetic Research Service Industry Trends Table 15. Pharmacokinetic Research Service Industry Drivers Table 16. Pharmacokinetic Research Service Industry Opportunities and Challenges Table 17. Pharmacokinetic Research Service Industry Restraints Table 18. Global Pharmacokinetic Research Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pharmacokinetic Research Service Revenue Market Share by Company (2021-2026) Table 20. Global Pharmacokinetic Research Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmacokinetic Research Service Key Company Head Office and Area Served Table 22. Global Pharmacokinetic Research Service Company, Product Type & Application Table 23. Global Pharmacokinetic Research Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmacokinetic Research Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pharmacokinetic Research Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pharmacokinetic Research Service Revenue Market Share by Type (2021-2026) Table 30. Global Pharmacokinetic Research Service Revenue Market Share by Type (2027-2032) Table 31. Global Pharmacokinetic Research Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021-2026) Table 35. Global Pharmacokinetic Research Service Revenue Market Share by Application (2027-2032) Table 36. Eurofins Company Information Table 37. Eurofins Business Overview Table 38. Eurofins Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Pharmacokinetic Research Service Product Portfolio Table 40. Eurofins Recent Development Table 41. PPD Company Information Table 42. PPD Business Overview Table 43. PPD Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. PPD Pharmacokinetic Research Service Product Portfolio Table 45. PPD Recent Development Table 46. LabCorp Company Information Table 47. LabCorp Business Overview Table 48. LabCorp Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. LabCorp Pharmacokinetic Research Service Product Portfolio Table 50. LabCorp Recent Development Table 51. Charles River Company Information Table 52. Charles River Business Overview Table 53. Charles River Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Charles River Pharmacokinetic Research Service Product Portfolio Table 55. Charles River Recent Development Table 56. BioPharma Services Company Information Table 57. BioPharma Services Business Overview Table 58. BioPharma Services Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BioPharma Services Pharmacokinetic Research Service Product Portfolio Table 60. BioPharma Services Recent Development Table 61. Biotrial Company Information Table 62. Biotrial Business Overview Table 63. Biotrial Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Biotrial Pharmacokinetic Research Service Product Portfolio Table 65. Biotrial Recent Development Table 66. QPS Holdings Company Information Table 67. QPS Holdings Business Overview Table 68. QPS Holdings Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. QPS Holdings Pharmacokinetic Research Service Product Portfolio Table 70. QPS Holdings Recent Development Table 71. Altasciences Company Information Table 72. Altasciences Business Overview Table 73. Altasciences Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Altasciences Pharmacokinetic Research Service Product Portfolio Table 75. Altasciences Recent Development Table 76. Allucent Company Information Table 77. Allucent Business Overview Table 78. Allucent Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Allucent Pharmacokinetic Research Service Product Portfolio Table 80. Allucent Recent Development Table 81. Admescope Company Information Table 82. Admescope Business Overview Table 83. Admescope Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Admescope Pharmacokinetic Research Service Product Portfolio Table 85. Admescope Recent Development Table 86. CTI Company Information Table 87. CTI Business Overview Table 88. CTI Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. CTI Pharmacokinetic Research Service Product Portfolio Table 90. CTI Recent Development Table 91. WuXi AppTec Company Information Table 92. WuXi AppTec Business Overview Table 93. WuXi AppTec Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. WuXi AppTec Pharmacokinetic Research Service Product Portfolio Table 95. WuXi AppTec Recent Development Table 96. GenScript Company Information Table 97. GenScript Business Overview Table 98. GenScript Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. GenScript Pharmacokinetic Research Service Product Portfolio Table 100. GenScript Recent Development Table 101. Wuxi Biologics Company Information Table 102. Wuxi Biologics Business Overview Table 103. Wuxi Biologics Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Wuxi Biologics Pharmacokinetic Research Service Product Portfolio Table 105. Wuxi Biologics Recent Development Table 106. Medicilon Company Information Table 107. Medicilon Business Overview Table 108. Medicilon Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Medicilon Pharmacokinetic Research Service Product Portfolio Table 110. Medicilon Recent Development Table 111. Pharmaron Company Information Table 112. Pharmaron Business Overview Table 113. Pharmaron Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Pharmaron Pharmacokinetic Research Service Product Portfolio Table 115. Pharmaron Recent Development Table 116. Frontage Company Information Table 117. Frontage Business Overview Table 118. Frontage Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Frontage Pharmacokinetic Research Service Product Portfolio Table 120. Frontage Recent Development Table 121. Shanghai Model Company Information Table 122. Shanghai Model Business Overview Table 123. Shanghai Model Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Shanghai Model Pharmacokinetic Research Service Product Portfolio Table 125. Shanghai Model Recent Development Table 126. North America Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 127. North America Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 128. North America Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 129. North America Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 130. North America Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Pharmacokinetic Research Service Market Size by Country (2021-2026) Table 132. North America Pharmacokinetic Research Service Market Size by Country (2027-2032) Table 133. Europe Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 134. Europe Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 135. Europe Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 136. Europe Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 137. Europe Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Pharmacokinetic Research Service Market Size by Country (2021-2026) Table 139. Europe Pharmacokinetic Research Service Market Size by Country (2027-2032) Table 140. China Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 141. China Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 142. China Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 143. China Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 145. Asia Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 146. Asia Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 147. Asia Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Pharmacokinetic Research Service Market Size by Country (2021-2026) Table 150. Asia Pharmacokinetic Research Service Market Size by Country (2027-2032) Table 151. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Type (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Type (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Application (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Application (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2021-2026) Table 157. South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Pharmacokinetic Research Service Product Image Figure 2. Global Pharmacokinetic Research Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacokinetic Research Service Market Share by Type: 2025 VS 2032 Figure 4. In Vitro and Radioactive ADME Image Figure 5. In Vivo PK and PD Image Figure 6. New Drugs and New Molecules Image Figure 7. Other Image Figure 8. Global Pharmacokinetic Research Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmacokinetic Research Service Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Industry Image Figure 11. Government and Ministry of Health Image Figure 12. Agriculture and Chemical Industry Image Figure 13. University Image Figure 14. Global Pharmacokinetic Research Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 16. Global Pharmacokinetic Research Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pharmacokinetic Research Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pharmacokinetic Research Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmacokinetic Research Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmacokinetic Research Service Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmacokinetic Research Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 26. North America Pharmacokinetic Research Service Market Share by Type (2021-2032) Figure 27. North America Pharmacokinetic Research Service Market Share by Application (2021-2032) Figure 28. North America Pharmacokinetic Research Service Market Share by Country (2021-2032) Figure 29. United States Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmacokinetic Research Service Market Share by Type (2021-2032) Figure 34. Europe Pharmacokinetic Research Service Market Share by Application (2021-2032) Figure 35. Europe Pharmacokinetic Research Service Market Share by Country (2021-2032) Figure 36. Germany Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 37. France Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmacokinetic Research Service Market Share by Type (2021-2032) Figure 44. China Pharmacokinetic Research Service Market Share by Application (2021-2032) Figure 45. Asia Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pharmacokinetic Research Service Market Share by Type (2021-2032) Figure 47. Asia Pharmacokinetic Research Service Market Share by Application (2021-2032) Figure 48. Asia Pharmacokinetic Research Service Market Share by Country (2021-2032) Figure 49. Japan Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 53. India Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Country (2021-2032) Figure 59. Brazil Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pharmacokinetic Research Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other
Applications
  • Pharmaceutical Industry
  • Government and Ministry of Health
  • Agriculture and Chemical Industry
  • University
Companies covered
  • Eurofins
  • PPD
  • LabCorp
  • Charles River
  • BioPharma Services
  • Biotrial
  • QPS Holdings
  • Altasciences
  • Allucent
  • Admescope
  • CTI
  • WuXi AppTec
  • GenScript
  • Wuxi Biologics
  • Medicilon
  • Pharmaron
  • Frontage
  • Shanghai Model

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacokinetic Research Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro and Radioactive ADME
  5. 1.2.3 In Vivo PK and PD
  6. 1.2.4 New Drugs and New Molecules
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmacokinetic Research Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Industry
  11. 1.3.3 Government and Ministry of Health
  12. 1.3.4 Agriculture and Chemical Industry
  13. 1.3.5 University
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pharmacokinetic Research Service Growth Trends by Region
  16. 1.5.1 Global Pharmacokinetic Research Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pharmacokinetic Research Service Market Size by Region (2021-2026)
  18. 1.5.3 Pharmacokinetic Research Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pharmacokinetic Research Service Market Dynamics
  1. 2.1 Pharmacokinetic Research Service Industry Trends
  2. 2.2 Pharmacokinetic Research Service Industry Drivers
  3. 2.3 Pharmacokinetic Research Service Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetic Research Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacokinetic Research Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacokinetic Research Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacokinetic Research Service Key Company Head office and Area Served
  4. 3.4 Global Pharmacokinetic Research Service Company, Product Type & Application
  5. 3.5 Global Pharmacokinetic Research Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacokinetic Research Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacokinetic Research Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacokinetic Research Service Tier 1, Tier 2, and Tier 3
4 Pharmacokinetic Research Service Market by Type
  1. 4.1 Global Pharmacokinetic Research Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacokinetic Research Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacokinetic Research Service Market Size Share by Type (2021-2032)
5 Pharmacokinetic Research Service Market by Application
  1. 5.1 Global Pharmacokinetic Research Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacokinetic Research Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacokinetic Research Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins
  2. 6.1.1 Eurofins Company Information
  3. 6.1.2 Eurofins Business Overview
  4. 6.1.3 Eurofins Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Pharmacokinetic Research Service Product Portfolio
  6. 6.1.5 Eurofins Recent Developments
  7. 6.2 PPD
  8. 6.2.1 PPD Company Information
  9. 6.2.2 PPD Business Overview
  10. 6.2.3 PPD Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 PPD Pharmacokinetic Research Service Product Portfolio
  12. 6.2.5 PPD Recent Developments
  13. 6.3 LabCorp
  14. 6.3.1 LabCorp Company Information
  15. 6.3.2 LabCorp Business Overview
  16. 6.3.3 LabCorp Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 LabCorp Pharmacokinetic Research Service Product Portfolio
  18. 6.3.5 LabCorp Recent Developments
  19. 6.4 Charles River
  20. 6.4.1 Charles River Company Information
  21. 6.4.2 Charles River Business Overview
  22. 6.4.3 Charles River Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Charles River Pharmacokinetic Research Service Product Portfolio
  24. 6.4.5 Charles River Recent Developments
  25. 6.5 BioPharma Services
  26. 6.5.1 BioPharma Services Company Information
  27. 6.5.2 BioPharma Services Business Overview
  28. 6.5.3 BioPharma Services Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 BioPharma Services Pharmacokinetic Research Service Product Portfolio
  30. 6.5.5 BioPharma Services Recent Developments
  31. 6.6 Biotrial
  32. 6.6.1 Biotrial Company Information
  33. 6.6.2 Biotrial Business Overview
  34. 6.6.3 Biotrial Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Biotrial Pharmacokinetic Research Service Product Portfolio
  36. 6.6.5 Biotrial Recent Developments
  37. 6.7 QPS Holdings
  38. 6.7.1 QPS Holdings Company Information
  39. 6.7.2 QPS Holdings Business Overview
  40. 6.7.3 QPS Holdings Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 QPS Holdings Pharmacokinetic Research Service Product Portfolio
  42. 6.7.5 QPS Holdings Recent Developments
  43. 6.8 Altasciences
  44. 6.8.1 Altasciences Company Information
  45. 6.8.2 Altasciences Business Overview
  46. 6.8.3 Altasciences Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Altasciences Pharmacokinetic Research Service Product Portfolio
  48. 6.8.5 Altasciences Recent Developments
  49. 6.9 Allucent
  50. 6.9.1 Allucent Company Information
  51. 6.9.2 Allucent Business Overview
  52. 6.9.3 Allucent Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Allucent Pharmacokinetic Research Service Product Portfolio
  54. 6.9.5 Allucent Recent Developments
  55. 6.10 Admescope
  56. 6.10.1 Admescope Company Information
  57. 6.10.2 Admescope Business Overview
  58. 6.10.3 Admescope Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Admescope Pharmacokinetic Research Service Product Portfolio
  60. 6.10.5 Admescope Recent Developments
  61. 6.11 CTI
  62. 6.11.1 CTI Company Information
  63. 6.11.2 CTI Business Overview
  64. 6.11.3 CTI Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 CTI Pharmacokinetic Research Service Product Portfolio
  66. 6.11.5 CTI Recent Developments
  67. 6.12 WuXi AppTec
  68. 6.12.1 WuXi AppTec Company Information
  69. 6.12.2 WuXi AppTec Business Overview
  70. 6.12.3 WuXi AppTec Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 WuXi AppTec Pharmacokinetic Research Service Product Portfolio
  72. 6.12.5 WuXi AppTec Recent Developments
  73. 6.13 GenScript
  74. 6.13.1 GenScript Company Information
  75. 6.13.2 GenScript Business Overview
  76. 6.13.3 GenScript Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 GenScript Pharmacokinetic Research Service Product Portfolio
  78. 6.13.5 GenScript Recent Developments
  79. 6.14 Wuxi Biologics
  80. 6.14.1 Wuxi Biologics Company Information
  81. 6.14.2 Wuxi Biologics Business Overview
  82. 6.14.3 Wuxi Biologics Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Wuxi Biologics Pharmacokinetic Research Service Product Portfolio
  84. 6.14.5 Wuxi Biologics Recent Developments
  85. 6.15 Medicilon
  86. 6.15.1 Medicilon Company Information
  87. 6.15.2 Medicilon Business Overview
  88. 6.15.3 Medicilon Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Medicilon Pharmacokinetic Research Service Product Portfolio
  90. 6.15.5 Medicilon Recent Developments
  91. 6.16 Pharmaron
  92. 6.16.1 Pharmaron Company Information
  93. 6.16.2 Pharmaron Business Overview
  94. 6.16.3 Pharmaron Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Pharmaron Pharmacokinetic Research Service Product Portfolio
  96. 6.16.5 Pharmaron Recent Developments
  97. 6.17 Frontage
  98. 6.17.1 Frontage Company Information
  99. 6.17.2 Frontage Business Overview
  100. 6.17.3 Frontage Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Frontage Pharmacokinetic Research Service Product Portfolio
  102. 6.17.5 Frontage Recent Developments
  103. 6.18 Shanghai Model
  104. 6.18.1 Shanghai Model Company Information
  105. 6.18.2 Shanghai Model Business Overview
  106. 6.18.3 Shanghai Model Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Shanghai Model Pharmacokinetic Research Service Product Portfolio
  108. 6.18.5 Shanghai Model Recent Developments
7 North America
  1. 7.1 North America Pharmacokinetic Research Service Market Size (2021-2032)
  2. 7.2 North America Pharmacokinetic Research Service Market Size by Type
  3. 7.2.1 North America Pharmacokinetic Research Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacokinetic Research Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacokinetic Research Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacokinetic Research Service Market Size by Application
  7. 7.3.1 North America Pharmacokinetic Research Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacokinetic Research Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacokinetic Research Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacokinetic Research Service Market Size by Country
  11. 7.4.1 North America Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacokinetic Research Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacokinetic Research Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacokinetic Research Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacokinetic Research Service Market Size (2021-2032)
  2. 8.2 Europe Pharmacokinetic Research Service Market Size by Type
  3. 8.2.1 Europe Pharmacokinetic Research Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacokinetic Research Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacokinetic Research Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacokinetic Research Service Market Size by Application
  7. 8.3.1 Europe Pharmacokinetic Research Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacokinetic Research Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacokinetic Research Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacokinetic Research Service Market Size by Country
  11. 8.4.1 Europe Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacokinetic Research Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacokinetic Research Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacokinetic Research Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacokinetic Research Service Market Size (2021-2032)
  2. 9.2 China Pharmacokinetic Research Service Market Size by Type
  3. 9.2.1 China Pharmacokinetic Research Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacokinetic Research Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacokinetic Research Service Market Share by Type (2021-2032)
  6. 9.3 China Pharmacokinetic Research Service Market Size by Application
  7. 9.3.1 China Pharmacokinetic Research Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacokinetic Research Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacokinetic Research Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacokinetic Research Service Market Size (2021-2032)
  2. 10.2 Asia Pharmacokinetic Research Service Market Size by Type
  3. 10.2.1 Asia Pharmacokinetic Research Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacokinetic Research Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacokinetic Research Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacokinetic Research Service Market Size by Application
  7. 10.3.1 Asia Pharmacokinetic Research Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacokinetic Research Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacokinetic Research Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacokinetic Research Service Market Size by Country
  11. 10.4.1 Asia Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacokinetic Research Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacokinetic Research Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacokinetic Research Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacokinetic Research Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacokinetic Research Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst